Core Viewpoint - The Schall Law Firm is investigating Aardvark Therapeutics, Inc. for potential violations of securities laws following a significant drop in share price due to safety concerns related to a late-stage trial pause [1][2]. Group 1: Investigation Details - The investigation focuses on whether Aardvark issued false or misleading statements or failed to disclose important information to investors [2]. - Aardvark paused its late-stage study for a rare disease treatment after discovering heart-related side effects during safety monitoring in a healthy volunteer study [2]. - Following the announcement of the trial pause, Aardvark's shares fell by over 47.3% in after-hours trading on the same day [2]. Group 2: Legal Representation - The Schall Law Firm is representing investors globally and specializes in securities class action lawsuits and shareholder rights litigation [3]. - Shareholders who suffered losses are encouraged to contact the firm to discuss their rights free of charge [3].